Leading brokers name 3 ASX shares to buy today

Here's why brokers rate these ASX shares as buys…

With so many shares to choose from on the ASX, it can be hard to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.

Three top ASX shares leading brokers have named as buys this week are listed below. Here's why they are bullish on them:

Business man marking buy on board and underlining it.

Image Source: Getty Images

Iluka Resources Limited (ASX: ILU)

According to a note out of Credit Suisse, its analysts have upgraded this mineral sands and rare earths miner's shares to an outperform rating with a $10.00 price target. This broker was pleased enough with Iluka's quarterly production and the strong prices it received. And while Credit Suisse has some small doubts over its production guidance, it isn't enough to stop it from upgrading its shares. Particularly given its catalyst-rich schedule which it feels could drive its shares higher. The Iluka share price is trading at $8.68 on Monday.

Macquarie Group Ltd (ASX: MQG)

A note out of Morgans reveals that its analysts have retained their add rating on this investment bank's shares with a trimmed price target of $214.30. This follows the release of a first half result which revealed a stronger than expected profit. Overall, Morgans highlights that Macquarie is a quality franchise, well exposed to structural growth areas, and is managing a more difficult FY 2023 environment well. The Macquarie share price is fetching $169.15.

ResMed Inc. (ASX: RMD)

Another note out of Morgans reveals that its analysts have retained their add rating on this sleep treatment company's shares with a slightly lower price target of $37.00. Morgans was pleased with ResMed's quarterly update, highlighting that its first quarter result was better than expected. So, with supply chain pressures easing, the broker believes that ResMed's outlook is very positive. The ResMed share price is trading at $33.98 on Monday afternoon.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed Inc. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia has positions in and has recommended ResMed Inc. The Motley Fool Australia has recommended Macquarie Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Couple using their digital tablet together.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Young successful engineer, with blueprints, notepad, and digital tablet, observing the project implementation on construction site and in mine.
Broker Notes

Why the Paladin Energy share price "doesn't make sense"

This uranium stock could be set for a major re-rating.

Read more »

Two miners standing together.
Broker Notes

3 ASX 200 mining shares to buy with 41% to 79% upside ahead: broker

The green energy transition and other factors are providing strong growth drivers for mining.

Read more »

Happy miner with his arms folded.
Broker Notes

Buy, hold, sell: Paladin Energy, Fortescue, Rio Tinto shares

Let's take a look at some new ratings from Morgans.

Read more »

a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.
Broker Notes

9 ASX 200 shares experts are backing for growth amid market weakness

Brokers retained a positive view on BHP, CSL, Telstra, Xero, and other shares this week. 

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

This ASX biotech could rise 40% or 750%, depending on who you ask

A poor quarter has reduced expectations, but there's still plenty of upside.

Read more »

Man using his device in an airport.
Broker Notes

This high-quality ASX 200 share could rise 60%

A leading broker expects a good yield and major upside from this stock.

Read more »

A baby's eyes open wide in surprise as it sucks on a milk bottle.
Broker Notes

Trading near 12-month lows, this ASX retailer could be set for a 54% gain

This baby goods retailer still has ample room to grow.

Read more »